Aytu Biopharma (AYTU) Intangibles (2014 - 2026)
Aytu Biopharma (AYTU) posted Intangibles of $41.4 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 1.9% from $42.2 million a year earlier and down 2.6% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Intangibles (2014 - 2026) Analysis & Trends
Since fiscal Q4 2015, Aytu Biopharma has reported Intangibles for 45 quarters.
- Annual Intangibles has declined for five consecutive fiscal years, with a five-year compound annual growth rate of -13.5% (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Intangibles was $42.2 million in FY2025 (-19.5%), $52.45 million in FY2024 (-11.1%), $58.97 million in FY2023 (-16.5%) and $70.63 million in FY2022 (-17.4%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Intangibles since fiscal Q3 2020.
- On a year-over-year basis, Intangibles has declined in each of the last 18 quarters, with an average decline of 12.1% over the last eight quarters.
- The strongest year-over-year quarter for Intangibles in the past five years was fiscal Q2 2022, with growth of 78.0%; the weakest was fiscal Q3 2022, with a decline of 22.7%.
- According to Business Quant data, Intangibles for the three prior fiscal quarters was $42.49 million (Q3 2026), $43.58 million (Q2 2026) and $41.43 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | 41.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.40 Mn |
| Mar 31, 2026 | 42.49 Mn |
| Dec 31, 2025 | 43.58 Mn |
| Sep 30, 2025 | 41.43 Mn |
| Jun 30, 2025 | 42.20 Mn |
| Mar 31, 2025 | 48.71 Mn |
| Dec 31, 2024 | 49.96 Mn |
| Sep 30, 2024 | 51.21 Mn |
| Jun 30, 2024 | 52.45 Mn |
| Mar 31, 2024 | 54.08 Mn |
| Dec 31, 2023 | 55.71 Mn |
| Sep 30, 2023 | 57.34 Mn |
| Jun 30, 2023 | 58.97 Mn |
| Mar 31, 2023 | 63.46 Mn |
| Dec 31, 2022 | 64.99 Mn |
| Sep 30, 2022 | 69.11 Mn |
| Jun 30, 2022 | 70.63 Mn |
| Mar 31, 2022 | 74.43 Mn |
| Dec 31, 2021 | 81.34 Mn |
| Sep 30, 2021 | 83.39 Mn |
API Access
Aytu Biopharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();